195 related articles for article (PubMed ID: 36266631)
1. Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study.
Thawani R; Gao L; Mohinani A; Tudorica A; Li X; Mitri Z; Huang W
BMC Med Imaging; 2022 Oct; 22(1):182. PubMed ID: 36266631
[TBL] [Abstract][Full Text] [Related]
2. Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
Machireddy A; Thibault G; Tudorica A; Afzal A; Mishal M; Kemmer K; Naik A; Troxell M; Goranson E; Oh K; Roy N; Jafarian N; Holtorf M; Huang W; Song X
Tomography; 2019 Mar; 5(1):90-98. PubMed ID: 30854446
[TBL] [Abstract][Full Text] [Related]
3. Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.
Tudorica A; Oh KY; Chui SY; Roy N; Troxell ML; Naik A; Kemmer KA; Chen Y; Holtorf ML; Afzal A; Springer CS; Li X; Huang W
Transl Oncol; 2016 Feb; 9(1):8-17. PubMed ID: 26947876
[TBL] [Abstract][Full Text] [Related]
4. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Dynamic-Enhanced MRI and Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Prediction of the Pathological Response to Neoadjuvant Chemotherapy and the Prognosis in Locally Advanced Gastric Cancer.
Zhu Y; Jiang Z; Wang B; Li Y; Jiang J; Zhong Y; Wang S; Jiang L
Front Oncol; 2022; 12():841460. PubMed ID: 35425711
[TBL] [Abstract][Full Text] [Related]
6. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
8. Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer.
Liang X; Chen X; Yang Z; Liao Y; Wang M; Li Y; Fan W; Dai Z; Zhang Y
BMC Cancer; 2022 Dec; 22(1):1250. PubMed ID: 36460972
[TBL] [Abstract][Full Text] [Related]
9. Intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging for neoadjuvant chemotherapy response evaluation in patients with osteosarcoma.
Yin P; Xu J; Sun X; Liu T; Chen L; Hong N
Eur J Radiol; 2023 May; 162():110790. PubMed ID: 36963332
[TBL] [Abstract][Full Text] [Related]
10. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
11. Nomogram based on quantitative dynamic contrast-enhanced magnetic resonance imaging, apparent diffusion coefficient, and clinicopathological features for early prediction of pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy.
He M; Su J; Ruan H; Song Y; Ma M; Xue F
Quant Imaging Med Surg; 2023 Jul; 13(7):4089-4102. PubMed ID: 37456283
[TBL] [Abstract][Full Text] [Related]
12. Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.
Feng Y; Liu H; Ding Y; Zhang Y; Liao C; Jin Y; Ai C
Tumori; 2020 Apr; 106(2):155-164. PubMed ID: 31736439
[TBL] [Abstract][Full Text] [Related]
13. Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation.
Böttcher J; Renz DM; Zahm DM; Pfeil A; Fallenberg EM; Streitparth F; Maurer MH; Hamm B; Engelken FJ
Acta Oncol; 2014 Jun; 53(6):759-68. PubMed ID: 24299492
[TBL] [Abstract][Full Text] [Related]
14. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
15. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
16. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: Perfusion metrics of dynamic contrast enhanced MRI.
Lee J; Kim SH; Kang BJ
Sci Rep; 2018 Jun; 8(1):9490. PubMed ID: 29934524
[TBL] [Abstract][Full Text] [Related]
18. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
Ren Z; Pineda FD; Howard FM; Fan X; Nanda R; Abe H; Kulkarni K; Karczmar GS
Magn Reson Imaging; 2023 Dec; 104():9-15. PubMed ID: 37611646
[TBL] [Abstract][Full Text] [Related]
19. Effect of Neoadjuvant Chemotherapy on Angiogenesis and Cell Proliferation of Breast Cancer Evaluated by Dynamic Enhanced Magnetic Resonance Imaging.
Chang L; Lan H
Biomed Res Int; 2022; 2022():3156093. PubMed ID: 35915805
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
